Course Description This lecture-based, three-hour virtual course covers 21 CFR Parts 210, 211, and 600. Topics include Current Good Manufacturing Practices (CGMPs), regulatory compliance, and maintaining a culture of quality …
The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility biotech training courses on CITI Program’s learning platform.
BioFlorida Spring Life Sciences Virtual Career Fair Friday, March 25, 2022 1:00 pm – 3:00 pm Meet with life sciences employers across the state to discuss open positions …
Join Biotility on Tuesday, March 29 at BioFlorida’s Northeast region Brews & Business event! Enjoy the relaxed setting of Cypress & Grove Brewery to meet new and established industry leaders …
Now in its 17th year, the Celebration of Biotechology is Florida’s Largest life sciences exhibit show. The Celebration offers guided bus tours of the Gainesville/Alachua biotech community, informative exhibits, music, …
In the early stages of the pharmaceutical drug approval process, it is essential to maximize outcomes of the Pre-Investigational New Drug (IND) meeting with FDA. Understanding how to navigate initial …
In the early stages of the pharmaceutical drug approval process, it is essential to maximize outcomes of the Pre-Investigational New Drug (IND) meeting with FDA. Understanding how to navigate initial …
In the early stages of the pharmaceutical drug approval process, it is essential to maximize outcomes of the Pre-Investigational New Drug (IND) meeting with FDA. Understanding how to navigate initial …
In the early stages of the pharmaceutical drug approval process, it is essential to maximize outcomes of the Pre-Investigational New Drug (IND) meeting with FDA. Understanding how to navigate initial …
In the early stages of the pharmaceutical drug approval process, it is essential to maximize outcomes of the Pre-Investigational New Drug (IND) meeting with FDA. Understanding how to navigate initial …